Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -$8.4M | -$2.2M | -$1.6M | -$446K | -$423K | |
| Operating Income | -$163.7M | -$230.7M | -$362.1M | -$64.8M | -$103.6M | |
| EBITDA | -$155.3M | -$228.5M | -$360.5M | -$64.3M | -$103.1M | |
| Diluted EPS | -$2.25 | -$2.47 | -$3.25 | -$0.66 | -$0.90 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $258.2M | $357.6M | $228.5M | $152.9M | $390.7M | |
| Total Assets | $298.4M | $390.3M | $250.7M | $179.1M | $411.7M | |
| Current Liabilities | $64.6M | $33.7M | $26.7M | $39.4M | $62M | |
| Total Liabilities | $111.1M | $97M | $83M | $99.9M | $166.7M | |
| Total Equity | $187.3M | $293.3M | $167.7M | $79.2M | $245M | |
| Total Debt | $53.7M | $63.3M | $56.3M | $60.6M | $104.8M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$136.8M | -$188.8M | -$274.1M | -$52.5M | -$68.9M | |
| Cash From Investing | $66.3M | $94.2M | -$15.7M | $35.3M | $59.7M | |
| Cash From Financing | $5.1M | $103.2M | $501.5M | $166K | $144.5M | |
| Free Cash Flow | -$137M | -$188.9M | -$274.6M | -$52.5M | -$69M | |
Scholar Rock Holding Corp. is a biopharmaceutical company. It engages in the business of discovering, developing, and delivering innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company was founded by Timothy A. Springer and Leonard I. Zon in October 2012 and is headquartered in Cambridge, MA.
In the current month, SRRK has received 11 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SRRK average analyst price target in the past 3 months is $47.33.
According to analysts, the consensus estimate is that Scholar Rock Holding Corp. share price will rise to $47.33 per share over the next 12 months.
Analysts are divided on their view about Scholar Rock Holding Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Scholar Rock Holding Corp. is a Sell and believe this share price will drop from its current level to $42.00.
The price target for Scholar Rock Holding Corp. over the next 1-year time period is forecast to be $47.33 according to 11 Wall Street analysts, 11 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for Scholar Rock Holding Corp. is a Buy. 11 of 11 analysts rate the stock a Buy at this time.
You can purchase shares of Scholar Rock Holding Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Scholar Rock Holding Corp. shares.
Scholar Rock Holding Corp. was last trading at $45.24 per share. This represents the most recent stock quote for Scholar Rock Holding Corp.. Yesterday, Scholar Rock Holding Corp. closed at $45.02 per share.
In order to purchase Scholar Rock Holding Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
With the market starting to look skittish on pure-play AI…
Market Cap: $4.4T
P/E Ratio: 62x
Market Cap: $4.1T
P/E Ratio: 37x
Market Cap: $3.9T
P/E Ratio: 40x
SMX (Security Matters) Plc [SMX] is down 59.64% over the past day.
Kymera Therapeutics, Inc. [KYMR] is up 41.67% over the past day.
Praxis Precision Medicines, Inc. [PRAX] is up 9.18% over the past day.